EA030227B1 - Мини-гранулы для пролонгированного высвобождения триметазидина, способ их получения и применение - Google Patents

Мини-гранулы для пролонгированного высвобождения триметазидина, способ их получения и применение Download PDF

Info

Publication number
EA030227B1
EA030227B1 EA201300079A EA201300079A EA030227B1 EA 030227 B1 EA030227 B1 EA 030227B1 EA 201300079 A EA201300079 A EA 201300079A EA 201300079 A EA201300079 A EA 201300079A EA 030227 B1 EA030227 B1 EA 030227B1
Authority
EA
Eurasian Patent Office
Prior art keywords
mini
granules
trimetazidine
accordance
retardant
Prior art date
Application number
EA201300079A
Other languages
English (en)
Russian (ru)
Other versions
EA201300079A2 (ru
EA201300079A3 (ru
Inventor
Патрик Женти
Кристоф Эрмелен
Жан-Манюэль Пеан
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47504206&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA030227(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA201300079A2 publication Critical patent/EA201300079A2/ru
Publication of EA201300079A3 publication Critical patent/EA201300079A3/ru
Publication of EA030227B1 publication Critical patent/EA030227B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EA201300079A 2012-02-03 2013-02-01 Мини-гранулы для пролонгированного высвобождения триметазидина, способ их получения и применение EA030227B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1200322A FR2986431B1 (fr) 2012-02-03 2012-02-03 Composition pharmaceutique a liberation prolongee de trimetazidine, son procede de fabrication et son utilisation dans des traitements therapeutiques

Publications (3)

Publication Number Publication Date
EA201300079A2 EA201300079A2 (ru) 2013-07-30
EA201300079A3 EA201300079A3 (ru) 2013-11-29
EA030227B1 true EA030227B1 (ru) 2018-07-31

Family

ID=47504206

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201300079A EA030227B1 (ru) 2012-02-03 2013-02-01 Мини-гранулы для пролонгированного высвобождения триметазидина, способ их получения и применение

Country Status (47)

Country Link
US (1) US10117838B2 (zh)
EP (1) EP2623096B1 (zh)
JP (1) JP6338818B2 (zh)
KR (2) KR20130090365A (zh)
CN (2) CN103239425A (zh)
AP (1) AP2013006693A0 (zh)
AR (1) AR089861A1 (zh)
AU (1) AU2013200481B2 (zh)
BR (1) BR102013002524B1 (zh)
CA (1) CA2805471C (zh)
CL (1) CL2013000336A1 (zh)
CO (1) CO6720159A1 (zh)
CR (1) CR20130037A (zh)
CU (1) CU24157B1 (zh)
CY (1) CY1121696T1 (zh)
DK (1) DK2623096T3 (zh)
DO (1) DOP2013000024A (zh)
EA (1) EA030227B1 (zh)
EC (1) ECSP13012415A (zh)
ES (1) ES2735053T3 (zh)
FR (1) FR2986431B1 (zh)
GE (1) GEP20156342B (zh)
GT (1) GT201300032A (zh)
HR (2) HRP20130082A2 (zh)
HU (1) HUE043942T2 (zh)
IL (1) IL224495B (zh)
JO (1) JO3505B1 (zh)
LT (1) LT2623096T (zh)
MD (1) MD4622C1 (zh)
MX (1) MX363302B (zh)
MY (1) MY162599A (zh)
NI (1) NI201300014A (zh)
PE (1) PE20131119A1 (zh)
PH (1) PH12013000031A1 (zh)
PL (1) PL2623096T3 (zh)
PT (1) PT2623096T (zh)
RO (1) RO128004A3 (zh)
RS (2) RS20130034A1 (zh)
RU (1) RU2621128C2 (zh)
SG (1) SG192386A1 (zh)
SI (1) SI2623096T1 (zh)
SV (1) SV2013004396A (zh)
TR (1) TR201906390T4 (zh)
TW (1) TWI508755B (zh)
UA (1) UA118742C2 (zh)
UY (1) UY34595A (zh)
WO (1) WO2013114053A2 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106163564B (zh) * 2014-04-08 2018-10-09 陶氏环球技术有限责任公司 包含酯化纤维素醚的分散体
EP4378457A2 (en) * 2016-11-21 2024-06-05 Saghmos Therapeutics, Inc. Prevention and/or treatment of contrast-induced acute kidney injury
CN109316455B (zh) * 2017-07-31 2021-05-25 北京福元医药股份有限公司 一种盐酸曲美他嗪缓释片
CN110237053A (zh) * 2019-07-26 2019-09-17 湖北欣泽霏药业有限公司 一种盐酸曲美他嗪缓释微丸及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1502995A (en) * 1994-03-24 1995-10-05 Les Laboratoires Servier Pharmaceutical compositions permitting the prolonged release of trimetazidine after oral administraiton
WO2003043610A2 (en) * 2001-11-21 2003-05-30 Themis Laboratories Private Limited A process for manufacture of a sustained release composition containing microbe
RU2281772C1 (ru) * 2005-02-14 2006-08-20 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Лекарственная форма, обладающая антиангинальным действием, и способ ее изготовления
RU2362548C1 (ru) * 2007-11-20 2009-07-27 Закрытое Акционерное Общество "Канонфарма Продакшн" Матричная таблетка с основой для пролонгированного высвобождения триметазидина дигидрохлорида, способ ее получения и способ лечения

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL270408A (zh) * 1960-10-20
FR2490963B1 (fr) 1980-09-30 1986-04-18 Science Union & Cie Nouvelle composition therapeutique a action anti-ischemique contenant de la trimethoxy 2, 3, 4-benzyl 1-piperazine
JPH04169522A (ja) * 1990-11-01 1992-06-17 Shin Etsu Chem Co Ltd 徐放性錠剤およびその製造方法
FR2802424B1 (fr) * 1999-12-17 2002-02-15 Adir Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale
PT1195160E (pt) * 2000-10-05 2009-12-07 Usv Ltd Composições farmacêuticas de trimetazidina de libertação sustentada e método para a sua preparação
EP2020995A2 (en) * 2006-05-09 2009-02-11 Mallinckrodt Inc. Zero-order modified release solid dosage forms
CN100571703C (zh) * 2006-12-20 2009-12-23 山东省医药工业研究所 曲美他嗪缓释微丸及其制备方法
CN103393623A (zh) * 2007-11-09 2013-11-20 田边三菱制药株式会社 新型制剂
US20110300209A1 (en) * 2009-01-20 2011-12-08 Micro Labs Limited Modified release solid pharmaceutical compositions of trimetazidine and process thereof
HUE027498T2 (en) * 2009-01-30 2016-10-28 Lupin Ltd Pharmaceutical preparations containing trimetazidine
WO2010105673A1 (en) * 2009-03-18 2010-09-23 Evonik Röhm Gmbh Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising a polymer mixture and excipients
PL2394644T3 (pl) * 2010-05-04 2014-11-28 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Preparat trimetazydyny o różnych profilach uwalniania
CN102133195A (zh) * 2011-03-17 2011-07-27 王国栋 盐酸曲美他嗪的缓控释微丸及其制备方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1502995A (en) * 1994-03-24 1995-10-05 Les Laboratoires Servier Pharmaceutical compositions permitting the prolonged release of trimetazidine after oral administraiton
WO2003043610A2 (en) * 2001-11-21 2003-05-30 Themis Laboratories Private Limited A process for manufacture of a sustained release composition containing microbe
RU2281772C1 (ru) * 2005-02-14 2006-08-20 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Лекарственная форма, обладающая антиангинальным действием, и способ ее изготовления
RU2362548C1 (ru) * 2007-11-20 2009-07-27 Закрытое Акционерное Общество "Канонфарма Продакшн" Матричная таблетка с основой для пролонгированного высвобождения триметазидина дигидрохлорида, способ ее получения и способ лечения

Also Published As

Publication number Publication date
EP2623096A3 (fr) 2013-10-23
PL2623096T3 (pl) 2019-08-30
ECSP13012415A (es) 2014-09-30
AU2013200481A1 (en) 2013-08-22
DK2623096T3 (da) 2019-07-15
GEP20156342B (en) 2015-08-10
WO2013114053A2 (fr) 2013-08-08
UY34595A (es) 2013-09-02
BR102013002524A2 (pt) 2014-09-09
MD20130005A2 (ro) 2013-07-31
KR20130090365A (ko) 2013-08-13
SI2623096T1 (sl) 2019-06-28
NI201300014A (es) 2013-05-13
AU2013200481B2 (en) 2015-01-22
SV2013004396A (es) 2013-06-05
CN106924221A (zh) 2017-07-07
JO3505B1 (ar) 2020-07-05
RS58752B1 (sr) 2019-06-28
RU2013104252A (ru) 2014-08-10
KR20150102922A (ko) 2015-09-09
NZ606550A (en) 2014-09-26
DOP2013000024A (es) 2014-07-15
IL224495B (en) 2020-08-31
CA2805471A1 (fr) 2013-08-03
ES2735053T3 (es) 2019-12-13
JP6338818B2 (ja) 2018-06-06
PE20131119A1 (es) 2013-10-12
MX363302B (es) 2019-03-20
GT201300032A (es) 2014-06-09
JP2013159609A (ja) 2013-08-19
MY162599A (en) 2017-06-30
CN103239425A (zh) 2013-08-14
RS20130034A1 (en) 2013-10-31
EA201300079A2 (ru) 2013-07-30
EP2623096A2 (fr) 2013-08-07
EA201300079A3 (ru) 2013-11-29
CU24157B1 (es) 2016-03-31
PH12013000031B1 (en) 2014-09-22
MD4622B1 (ro) 2019-03-31
RO128004A0 (ro) 2012-12-28
AP2013006693A0 (en) 2013-01-31
FR2986431B1 (fr) 2017-03-17
AR089861A1 (es) 2014-09-24
PH12013000031A1 (en) 2014-09-22
CA2805471C (fr) 2018-05-01
BR102013002524B1 (pt) 2020-02-04
CU20130016A7 (es) 2014-10-02
US20130202710A1 (en) 2013-08-08
CO6720159A1 (es) 2013-07-31
TR201906390T4 (tr) 2019-05-21
EP2623096B1 (fr) 2019-04-03
HRP20191072T1 (hr) 2019-11-01
PT2623096T (pt) 2019-05-30
UA118742C2 (uk) 2019-03-11
HRP20130082A2 (hr) 2013-08-31
US10117838B2 (en) 2018-11-06
CL2013000336A1 (es) 2014-07-18
TW201332591A (zh) 2013-08-16
WO2013114053A3 (fr) 2013-12-19
CY1121696T1 (el) 2020-07-31
RU2621128C2 (ru) 2017-05-31
SG192386A1 (en) 2013-08-30
HUE043942T2 (hu) 2019-09-30
TWI508755B (zh) 2015-11-21
RO128004A3 (ro) 2013-08-30
MD4622C1 (ro) 2019-10-31
MX2013001118A (es) 2013-08-27
FR2986431A1 (fr) 2013-08-09
CR20130037A (es) 2013-09-18
KR101918211B1 (ko) 2018-11-14
LT2623096T (lt) 2019-05-10

Similar Documents

Publication Publication Date Title
ES2683864T3 (es) Composiciones de corticosteroides administradas oralmente
JP6258382B2 (ja) 過活動膀胱の治療のための医薬製剤
JP5911969B2 (ja) 心臓血管障害の治療方法
JP6356215B2 (ja) エベロリムスを含む医薬組成物
MXPA05001538A (es) Distribuidor de tipo manguito de endoscopio.
JP2013501718A5 (zh)
KR20100014629A (ko) 타크로리무스의 변형제형
JP3017040B2 (ja) トリメタジジンの経口投与用持続的放出型薬剤組成物
KR20190119046A (ko) N-아세틸시스테인의 제제 및 이의 용도
JP2011502131A5 (zh)
EA030227B1 (ru) Мини-гранулы для пролонгированного высвобождения триметазидина, способ их получения и применение
JP6832973B2 (ja) ビロキサジンの緩和放出製剤
WO2015019256A1 (en) Pharmaceutical composition of vilazodone and processes of preparation thereof
EP3219311A1 (en) Pharmaceutical composition comprising dabigatran etexilate, and preparation method, solid preparation and use thereof
MXPA05001559A (es) Composiciones de mononitrato de isosorbide y metodos de uso de las mismas.
NZ606550B (en) Pharmaceutical composition for the prolonged release of trimetazidine
MX2007016151A (es) Composiciones de liberacion controlada y en forma de nano-particulas que comprenden compuestos aril-heterociclicos.
OA16427A (en) Composition pharmaceutique à libération prolongée de trimétazidine.
BR102016004595A2 (pt) composição farmacêutica sólida com anti-histamínico não sedativo e descongestionante